Table 3 Application of ferroptosis-related miRNAs in tumor therapy.
From: Emerging roles of ferroptosis-related miRNAs in tumor metastasis
miRNA | Disposes | Cancer types | Expression levels in the sample | Models of evidence | References |
|---|---|---|---|---|---|
miR-214 | – | Prostate cancer | Downregulate | Clinical trials | [129] |
miR-27a-3p | – | Prostate cancer | Upregulate | Clinical trials | [130] |
miR-9 | – | Nasopharyngeal carcinoma | Downregulate | Clinical trials | [131] |
miR-17-92 | – | Gastric cancer | Upregulate | Clinical trials | [132] |
miR-375 | – | Hepatocellular carcinoma | Downregulate | Clinical trials | [133] |
miR-324-3p | – | Hepatocellular carcinoma | Downregulate | Clinical trials | [134] |
miR-375 | – | Colorectal carcinoma | Downregulate | Clinical trials | [135] |
miR-137 | – | Glioblastoma | Downregulate | Clinical trials | [136] |
miR-324-3p | Icariside II | RCC | Upregulate | Cell culture | [108] |
miR-214-3p | Ketamine | Liver cancer | Upregulate | Cell culture, animal models | [109] |
miR-101-3p | Nanoparticle-coated | Lung cancer | Upregulate | Cell culture, animal models | [110] |
miR-21-3p | Nanoparticle-coated | Melanoma | Upregulate | Cell culture, animal models | [137] |
miR-744-5p | Propofol | NSCLC | Upregulate | Cell culture, animal models | [138] |
